TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, vol.25, no.1, pp.58-67, 2022 (Journal Indexed in SCI)
Article / Article
Title of Journal :
TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI
Multiple Myeloma, Aged, Therapeutics, CYCLOPHOSPHAMIDE, DEXAMETHASONE, CRITERIA, RISK
Introduction: Elderly patients with multiple myeloma have shorter survival outcomes than younger patients. In this study, we aimed to compare the efficacy and toxicity profiles of conventional and bortezomib-based therapy as first-line therapy in elderly patients with multiple myeloma and to determine the prognostic factors.